ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2012, Vol. 21 ›› Issue (5): 435-438.

• 论文 • 上一篇    下一篇

代谢综合征对腹膜透析患者预后的影响

  

  • 出版日期:2012-10-24 发布日期:2012-10-24

A relationship of metabolic syndrome and the mortality in patients with peritoneal dialysis

  • Online:2012-10-24 Published:2012-10-24

摘要:

摘  要  目的:通过分析腹膜透析患者规律随访资料,探讨代谢综合症(MS)与生存率之间的关系。方法:选取我院腹透中心2007年05月至2008年05月选择腹膜透析并规律定期随访的患者108例,共规律随访4年。代谢综合征的定义使用修改后的NCEP ATP III, 2001 诊断标准定义。按照是否诊断为MS分为MS组和非MS组。两组患者累计生存率的估计用Kaplan-Meier方法,Cox比例风险模型用于死亡率相对危险度的比较。 结果:基线水平时44例(40.7%)患者符合MS的诊断,MS组的累积生存率为76.9%,非MS为46.5%,经Log-Rank检验进行比较:P=0.001。校正混杂因素后经多因素Cox比例风险分析示MS组相对危险度RR:2.336 (95%CI:1.078-4.070;P=0.029)。 结论:代谢综合征在腹膜透析患者中具有较高的死亡率,是影响患者预后的独立危险因素。

关键词: 腹膜透析, 生存率, 代谢综合征, COX分析

Abstract:

ABSTRACT Objective: The regular follow-up materials were collected retrospectively, the relationship of metabolic syndrome(MS)and the mortality in patients with peritoneal dialysis (PD) was investigated. Methodology: One hundred and eight patients with PD were enrolled in this study, and followed up regularly from July 2007 to July 2008. The definition of metabolic syndrome was modified NCEP ATP III, 2001 diagnosis standard definition. According to whether or not diagnosis as MS, they were divided into MS group and without MS group. The total survival estimate Kaplan-Meier method, and Cox ratio for mortality risk model the comparison of the relative risk was used to evaluate the survival rate and mortality in different two groups. Results: There were 44 cases (40.7%) patients with the metabolic syndrome on baseline. The cumulative survival rate was 76.9% in MS group, while 46.5% in non-MS group, two groups of survival after Log-Rank inspection: P=0.001. Calibration confounding factors by multiple factors Cox proportion risk analysis, metabolic syndrome relative risk was RR:2.336 (95% CI, 1.078 to 4.070; P = 0.029). Conclusion: The peritoneal dialysis patients with metabolic syndrome have a high mortality, which is a predicting independent risk factors for survival.

Key words: Peritoneal dialysis , Survival rate , Metabolic Syndrome  , COX analysis